Aerami Therapeutics Company
Aerami Therapeutics focuses on developing novel inhaled therapies for the treatment of chronic diseases. It features a proprietary, smart, handheld soft mist device that allows convenient and confident delivery of insulin into a patient's lungs in just a few breaths yielding high lung deposition and distribution. It was founded in 2010 and headquartered in Durham, North Carolina.
Technology:
Anti-infective Drugs
Industry:
PharmTech
Headquarters:
Durham, North Carolina, United States
Zip:
11-50
Founded Date:
2010-01-01
Employees Number:
11-50
Acquisitions Number:
3
Investors Number:
155794560
Total Funding:
Less than $1M
Estimated Revenue:
Less than $1M
Last Funding Date:
Series B
Last Funding Type:
info@aerami.com
Register and Claim Ownership